Acalypha wilkesiana and Mirabilis jalapa extracts synergistically disrupt bacterial membranes and inhibit protein maturation/quorum sensing in MRSA and P. aeruginosa.
Background
The increasing global threat of multidrug-resistant (MDR) skin pathogens, particularly methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa, necessitates novel therapeutic strategies beyond conventional single-target antibiotics. These bacteria are major contributors to difficult-to-treat infections, including surgical site infections and prosthetic joint infections (PJI), where mortality rates can be significant. Ethnopharmacology, leveraging traditional plant-based remedies, offers a promising avenue to discover new compounds with multi-targeting mechanisms to overcome resistance.
Study Design
Researchers investigated the antimicrobial, synergistic, and molecular mechanisms of Acalypha wilkesiana and Mirabilis jalapa leaf extracts. Ethanol and aqueous extracts were prepared and purified via silica gel column chromatography. Antimicrobial efficacy was determined using Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays. Synergism was assessed by the checkerboard method, calculating the Fractional Inhibitory Concentration Index (FIC index). Membrane integrity was probed via K+ and protein leakage assays. Key phytochemicals, Quercetin and Chlorogenic Acid, were then docked against S. aureus Peptide Deformylase (PDF; PDB: 1Q1Y) and P. aeruginosa LasR (PDB: 2UV0), followed by 50-ns Molecular Dynamics (MD) simulations and MM-GBSA binding free energy calculations.
Results
Ethanol extracts of A. wilkesiana showed potent activity, with an MIC of 12.5 mg/ml against P. aeruginosa ATCC 10145. When combined with M. jalapa extracts, strong synergy was observed, indicated by an FIC index of ≤ 0.25-0.50. Membrane leakage assays revealed significant cellular damage: K+ leakage measured 15.86 Cmol/kg and protein efflux was 3.83 Cmol/kg, suggesting catastrophic membrane failure. In silico, Quercetin exhibited high-affinity inhibition of S. aureus PDF, achieving a docking score of -9.802 kcal/mol and an MM-GBSA ΔGbind of -58.42 kcal/mol, with an RMSD of 1.45 ± 0.2 Å. Critical H-bonds at Gly49/Gln50 were maintained for 88% of the simulation frames. Similarly, Chlorogenic Acid bound effectively to the LasR autoinducer pocket, with a docking score of -9.7 kcal/mol and an MM-GBSA of -48.15 kcal/mol, showing an RMSD of 1.80 ± 0.3 Å. Hydrophobic contacts at Trp60 persisted for 95% of its trajectory. These findings suggest that Quercetin suppresses bacterial protein maturation via PDF inhibition, while Chlorogenic Acid disrupts quorum-sensing via LasR binding.
The combination of A. wilkesiana and M. jalapa extracts demonstrated strong synergy, achieving an
FIC indexof ≤ 0.25-0.50, indicating a highly effective multi-targeting approach against resistant bacteria.
Key Findings
- Ethanol extracts of A. wilkesiana showed potent antimicrobial activity, with an
MICof 12.5 mg/ml againstP. aeruginosa ATCC 10145. - Combination of A. wilkesiana and M. jalapa extracts yielded strong synergy, with an
FIC indexof ≤ 0.25-0.50. - Extracts induced significant membrane damage, evidenced by 15.86 Cmol/kg K+ leakage and 3.83 Cmol/kg protein efflux.
- Quercetin strongly inhibited
S. aureus Peptide Deformylase (PDF)with a docking score of -9.802 kcal/mol andMM-GBSA ΔGbindof -58.42 kcal/mol. - Chlorogenic Acid bound
P. aeruginosa LasRwith a docking score of -9.7 kcal/mol andMM-GBSAof -48.15 kcal/mol, disrupting quorum sensing.
Why It Matters
This research highlights the significant potential of natural product-derived antimicrobials as a multi-targeting strategy against MDR pathogens like MRSA and P. aeruginosa. By simultaneously disrupting bacterial membranes and inhibiting crucial processes like protein maturation (PDF) and quorum sensing (LasR), these plant extracts could circumvent single-target resistance mechanisms. Future wound care protocols might integrate these compounds, offering a novel approach to manage persistent infections where conventional antibiotics fail. This work provides a strong foundation for isolating active compounds and developing new topical or systemic treatments, potentially reducing the burden of post-surgical infections and chronic wounds.
acalypha-wilkesiana
mirabilis-jalapa
mrsa
pseudomonas-aeruginosa
antimicrobial
ethnopharmacology